Patents by Inventor Hervé Guillard

Hervé Guillard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240108594
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Application
    Filed: September 14, 2023
    Publication date: April 4, 2024
    Inventors: Claire Mégret, Hervé Guillard, Jean-François Dubuisson
  • Patent number: 11896572
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Grant
    Filed: August 8, 2023
    Date of Patent: February 13, 2024
    Assignee: Flamel Ireland Limited
    Inventors: Jordan Dubow, Hervé Guillard, Claire Mégret, Jean-François Dubuisson
  • Patent number: 11839597
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: December 12, 2023
    Assignee: Flamel Ireland Limited
    Inventors: Claire Megret, Herve Guillard, Jean-Francois Dubuisson
  • Publication number: 20230381131
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Application
    Filed: August 8, 2023
    Publication date: November 30, 2023
    Inventors: Jordan Dubow, Hervé Guillard, Claire Mégret, Jean-François DUBUISSON
  • Patent number: 11826335
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Grant
    Filed: January 12, 2023
    Date of Patent: November 28, 2023
    Assignee: Flamel Ireland Limited
    Inventors: Jordan Dubow, Hervé Guillard, Claire Mégret, Jean-François Dubuisson
  • Patent number: 11779557
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Grant
    Filed: February 7, 2022
    Date of Patent: October 10, 2023
    Assignee: Flamel Ireland Limited
    Inventors: Jordan Dubow, Cendrine Grangeon, Hervé Guillard, Claire Mégret, Jean-François Dubuisson
  • Patent number: 11766418
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Grant
    Filed: December 6, 2022
    Date of Patent: September 26, 2023
    Assignee: Flamel Ireland Limited
    Inventors: Jordan Dubow, Hervé Guillard, Claire Mégret, Jean-François Dubuisson
  • Publication number: 20230210804
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Application
    Filed: March 10, 2023
    Publication date: July 6, 2023
    Inventors: Jordan Dubow, Hervé Guillard, Claire Mégret, Jean-François Dubuisson
  • Publication number: 20230172893
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Application
    Filed: January 12, 2023
    Publication date: June 8, 2023
    Inventors: Jordan DUBOW, Hervé GUILLARD, Claire Mégret, Jean-François DUBUISSON
  • Publication number: 20230172892
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Application
    Filed: December 6, 2022
    Publication date: June 8, 2023
    Inventors: Jordan Dubow, Hervé Guillard, Claire Mégret, Jean-François DUBUISSON
  • Patent number: 11602513
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Grant
    Filed: October 8, 2021
    Date of Patent: March 14, 2023
    Assignee: Flamel Ireland Limited
    Inventors: Jordan Dubow, Hervé Guillard, Claire Mégret, Jean-François Dubuisson
  • Patent number: 11602512
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Grant
    Filed: October 8, 2021
    Date of Patent: March 14, 2023
    Assignee: Flamel Ireland Limited
    Inventors: Jordan Dubow, Hervé Guillard, Claire Mégret, Jean-François Dubuisson
  • Patent number: 11583510
    Abstract: Provided herein are methods of administering a once-nightly dosage of gamma-hydroxybutyrate after a high-fat meal.
    Type: Grant
    Filed: February 7, 2022
    Date of Patent: February 21, 2023
    Assignee: Flamel Ireland Limited
    Inventors: Julien Grassot, David Monteith, Hervé Guillard, Claire Mégret, Jean-François Dubuisson
  • Patent number: 11504347
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Grant
    Filed: October 8, 2021
    Date of Patent: November 22, 2022
    Assignee: Flamel Ireland Limited
    Inventors: Julien Grassot, Hervé Guillard, Claire Mégret, Jean-François Dubuisson
  • Publication number: 20220317637
    Abstract: A predictive control method and system are provided for controlling a device or system. The control method and system involves receiving a setpoint signal as input; and performing closed loop control of the device or system by outputting a control signal according to the setpoint signal and a response model of the device or system using a predictive control algorithm. The predictive control algorithm is configured to implement control according to a polynomial representation for regulation, sensitivity and tracking and further implement non-linearity or time delay compensation using the response model. The closed loop control is tunable using an adjustable single parameter for accelerating or decelerating the closed loop control relative to an open loop control scenario.
    Type: Application
    Filed: January 21, 2022
    Publication date: October 6, 2022
    Applicants: Schneider Electric Industries SAS, CONSERVATOIRE NATIONAL DES ARTS ET MÉTIERS
    Inventors: Franco Falconi, Stefan Capitaneanu, Hervé Guillard, Tarek Raïssi
  • Publication number: 20220016066
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Application
    Filed: September 24, 2021
    Publication date: January 20, 2022
    Inventors: Claire Megret, Herve Guillard, Jean-Francois Dubuisson
  • Publication number: 20210267928
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Application
    Filed: May 17, 2021
    Publication date: September 2, 2021
    Inventors: Claire Megret, Herve Guillard, Jean-Francois Dubuisson
  • Patent number: 11065224
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Grant
    Filed: July 31, 2019
    Date of Patent: July 20, 2021
    Assignee: Flamel Ireland Limited
    Inventors: Claire Megret, Herve Guillard, Jean-Francois Dubuisson
  • Patent number: 11052061
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Grant
    Filed: May 22, 2019
    Date of Patent: July 6, 2021
    Assignee: Flamel Ireland Limited
    Inventors: Claire Megret, Herve Guillard, Jean-Francois Dubuisson
  • Publication number: 20210186916
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Application
    Filed: March 8, 2021
    Publication date: June 24, 2021
    Inventors: Claire Megret, Herve Guillard, Jean-Francois Dubuisson